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9ABBREVIATIONS
BMI =  Body mass index
BF =  Breathing frequency
CV = Closing volume
CC = Closing capacity = CV+RV
ERV = Expiratory reserve volume
FETCO2 = End expiratory tidal CO2 fraction
FEV1 = Forced expiratory volume in one second
FIV1 = Forced inspiratory volume in one second
FRC = Functional residual capacity
FVC = Forced vital capacity
MMEF = FEF25-75 = Flow rate at the middle part of FVC
MEF50 = Maximal flow at a volume of 50% of FVC
MEF25 = Maximal flow at a volume of 25% of FVC
MVV = Maximal voluntary ventilation
ODI4 = The number of 4 percent or greater desaturation events per hour in bed
PaO2 =  Arterial oxygen tension
PaCO2 = Arterial carbon dioxide tension
P(A-a)O2 = Alveolar arterial O2 difference
PEF = Peak expiratory flow
PIF = Peak inspiratory flow
Raw = Airways resistance
RR = Respiratory rate
RV = Residual volume
SGaw = Airways conductance
TLC = Total lung capacity
VAS =  Visual analogue scaleVE = Minute ventilation
VE/VCO2 = Ventilatory  equivalent for CO2
VE/VO2 = Ventilatory equivalent for O2
VLCD = Very-low-calorie-diet
VO2 = oxygen uptake, oxygen consumption
VCO2 = carbon dioxide output, carbon dioxide production
VT = Tidal volume
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INTRODUCTION
Obesity is one of the most frequently found health risks and the prevalence of
obesity appears to be increasing all over the world (Seidell et al. 1998, WHO:
Obesity, 1998). In Finland, as in most European countries, one-fifth of adults
are obese, with body mass index (BMI) more than 30 kg/m2 (Pietinen et al.
1996). Health risks increase with increasing degree of obesity (Bray et al.
1998).
Obesity is associated with increased risks of respiratory symptoms, including
shortness of breath and wheezing (Lean et al. 1999). The most characteristic
changes in pulmonary function in obese persons are decreased functional
residual capacity (FRC) and expiratory reserve volume (ERV) (Luce 1980,
Ray et al. 1983). Pulmonary function abnormalities are more common in
central obesity (Collins et al. 1995, Lazarus et al. 1997 and 1998). Recently, it
has been questioned whether the effect of obesity on pulmonary function is
simply a mechanical one or if it is one more consequence of central obesity
(Sue 1997).
Obesity is regarded as a major risk factor for obstructive sleep apnea syndrome
(OSAS) (Guilleminault et al. 1988, Douglas et al. 1994). In weight loss
studies, a significant improvement in both symptoms and objective findings of
OSAS after weight reduction has been demonstrated (Strobel et al. 1996,
Lojander et al. 1998). Recently, increasing epidemiological evidence has
suggested that there is an association between asthma and obesity (Shaheen
1999a, Wilson et al. 1999).  At present, it is not possible to say whether
obesity has contributed to the rise in asthma prevalence or whether asthma
patients gain weight as a result of activity limitations or some other reasons.
The isolated effects of obesity on respiratory function must be known in order
to evaluate the contribution of obesity to the dysfunction seen in different
respiratory diseases. The studies in this thesis were designed to evaluate the
effects of dietary induced weight loss on respiratory complications of obesity
and further to determine the impact of obesity on respiratory function in OSAS
patients and in asthmatics. Especially, gas exchange in response to standing up
and during exercise was studied in order to find characteristic features of
hypoxemia associated with obesity.
                INTRODUCTION
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REVIEW OF THE LITERATURE
1. OBESITY
1.1. Definition and classification of obesity
Obesity is defined as an excessive accumulation of fat that causes a
generalized increase in body mass. Several definitions and cutoff points have
been used to define overweight and the degree of obesity. The most commonly
used indicator of general adiposity is body mass index (BMI), calculated as
weight in kilograms divided by the square of the height in meters. World
Health Organization (WHO) (1995) and National Institutes of Health (NIH)
(1998) have recommended the classification of BMI using cutoff points of 25
kg/m2 and 30 kg/m2, i.e. overweight BMI 25-30 kg/m2, and obesity BMI of 30
kg/m2 or higher.
The risks of morbidity and mortality seem to increase with increasing BMI.
Classification of obesity based on BMI and health risk described by Bray
(1985)(Table 1) is widely used in Europe.
Table 1. Classification of obesity  (Bray, 1985).
     BMI (kg/m2) Class Health risk
            BMI  < 25 normal weight very low
    25 < BMI < 30 overweight low
    30 < BMI < 35 moderate obesity moderate
    35 < BMI < 40 severe obesity high
    40 < BMI morbid obesity very high
In addition to the degree of obesity, the distribution of excess fat affects the
health risks of obesity. Several cardiovascular and metabolic complications are
related to abdominal visceral obesity (Björntorp 1996, Seidell et al. 1999). A
commonly used measure of body fat distribution is the waist-to-hip ratio
(WHR). WHR over 0.95 in men and over 0.80 in women indicates increased
   REVIEW OF THE LITERATURE
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risk of cardiovascular and metabolic disturbances (Björntorp 1996, Seidell
et.al 1999). Pouliot et al. (1994) reported that waist circumference better than
WHR correlates with the amount of visceral fat, especially in women. The use
of BMI and waist circumference together as a measure for the assessment of
health risks of obesity is illustrated in Figure 1.
Figure 1.
The association of BMI and waist
circumference with the risk of
morbidity  (Fogelholm et al. 1998).
1.2. Prevalence of obesity
Obesity is an increasing health problem all over the world (Seidell et al. 1998,
WHO: Obesity, 1998). In ten years the prevalence of obesity has increased by
10 - 40 % in most European countries. In 1997 in Finland the prevalence of
obesity (BMI > 30 kg/m2) was 19 % in adult population (Lahti-Koski et al.
1999). The prevalence of overweight (BMI > 25 kg/m2) was 48 % among men
and 32 % among women aged 30 - 59 years.
In terms of medication, provision of health services, and absences from work,
the overall costs of obesity are considerable. The estimated health care costs of
obesity in 1997 in Finland were 0.9 - 3.2 billion marks, representing 1.4 -7.0 %
of the total costs of health care (Pekurinen et al. 2000).
1.3. Respiratory complications of obesity
The most common medical problems attributed to obesity include non-insulin
dependent diabetes mellitus, hypertension, dyslipidemia, cardiovascular
disease, and osteoarthritis (Rissanen et al. 1990, Manson et al. 1990 and 1995).
Less known, but no less important, are the effects of obesity on respiratory
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physiology (Strohl et al. 1998). Body fat distribution may have simple
mechanical effects on lung volumes. Fat stored within the abdominal cavity,
abdominal wall and chest wall is likely to directly compress the thoracic cage,
diaphragm, and lung and reduce lung volumes (Sue 1997). Conversely, it has
been postulated that adipose tissue added to the lower body would be too
distant to affect lung volumes. Overall obesity and the pattern of fat
distribution may have independent effects on ventilatory function (Lazarus et
al. 1997). Collins et al. (1995) reported that high WHR was inversely related to
spirometric and static lung volumes. But is the effect of abdominal body fat
distribution on lung function simply a mechanical one? While mechanisms
connecting cardiovascular and metabolic risks of abdominal obesity to
pulmonary function are not known, adverse effects on pulmonary function may
be one more consequence of central obesity (Sue 1997).
Respiratory symptoms
Overweight and obesity are associated with increased risks of respiratory
symptoms (Sahebjami 1998). The prevalence of symptoms increases with
increasing BMI (Lean et al. 1999) or waist circumference (Lean et al. 1998). In
the cross-sectional survey of 5887 men and 7018 women aged 29 to 59 years
from the Netherlands there were 45 % men and 31 % women with a BMI 25 -
30 kg/m2, and 11 % men and 11 women with a BMI > 30 kg/m2. The
prevalence of wheezing and shortness of breath when walking uphill / upstairs
increased with increasing BMI. The odds ratios in those with a BMI over 30
kg/m2 or higher were 3.5 (95% CI, 2.8-4.4) in men and 3.3 (95% CI, 2.8-3.9)
in women for shortness of breath compared with the reference group of BMI
below 25 kg/m2.  The odds ratios for wheezing were 1.5 (95% CI, 1.13-2.0) in
men and 1.99 (95% CI, 1.55-2.57) in women respectively (Lean et al. 1999).
Lung volumes and expiratory flow rates
The most common abnormality in pulmonary function recognized in obesity is
a decrease in expiratory reserve volume (ERV) and functional residual
capacity (FRC) (Ray et al. 1993, Sahebjami et al. 1996, Biring et al. 1999). In
mild to moderate obesity VC and TLC are usually within normal range, but in
morbid obesity they may be reduced by 20-30 % compared to predicted values
(Zerah et al. 1993). Ray et al. (1983) emphasized that only in extreme obesity
TLC and VC may be reduced. According to some other studies, however, the
decrease in lung volumes has been in proportion to the degree of obesity
(Zerah et al. 1993, Strohl et al. 1998). In addition, Zerah et al. (1993) showed
         REVIEW OF THE LITERATURE
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that changes in FRC, ERV, VC and TLC correlated with each other. In
general, residual volume (RV) is not reduced in obesity. It has been assumed
(Sharp et al. 1964a) that mass loading of chest wall with limited function of
expiratory muscles as well as high closing volume in relation to ERV help to
maintain residual volume even in morbid obesity. RV related to TLC
(RV/TLC) may even be higher than normal in morbid obesity (Ray et al.
1983).
Figure 2. Summary of the effects of
               obesity on lung volumes.
VC   = Vital Capacity
TLC = Total Lung Capacity
FRC = Functional Residual Capacity
ERV = Expiratory Reserve Volume
RV   = Residual Volume
VT   = Tidal Volume
Recently, the longitudinal relationship between adiposity and FEV1 was
investigated in a national study of British adults (Carey et al. 1999). The
follow-up period was 7 years. Changes in weight or BMI were related to
changes in FEV1. The authors concluded that increase in body mass is a
predictor of FEV1 decline, especially in older and heavier men. Several studies
have reported that with increasing BMI the decrease in FEV1 is in proportion
to the change in FVC (Rubinstein et al. 1990), so that the FEV1 / FVC ratio
usually remains normal (Thomas et al. 1989).
Expiratory flow rates at low lung volumes (FEF25-75) may decrease with
increasing obesity suggesting narrowing of the small airways (Rubinstein et al.
1990). It is possible that narrowing of the peripheral airways is associated with
increased bronchial responsiveness. While using FEF25-75 / FVC ratio as a
measure of airways size related to lung size, Litonjua et al. (1999) found a
significant association between FEF25-75 / FVC and methacholine airway
responsiveness. Exercise induced bronchospasm (EIB) has been studied in
obese children aged 6 to 10 years (Kaplan et al. 1993). The degree and
frequency of EIB was higher in obese compared to non-obese children. The
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causal relationship between obesity and bronchial hyperresponsiveness has not
yet been proved. Whether EIB leads to exercise avoidance and obesity, or
whether obesity increases bronchial responsiveness needs further studies.
Closing volume, air trapping, and gas exchange
Closure of peripheral airways within dependent lung regions occurs in normal
subjects during a maximal expiration. Closing volume (CV) is defined as the
lung volume at which this closure occurs (Leblanc et al. 1970). The
relationship of closing volume to ERV is important when we evaluate the
tendency to increased small airway closure in obesity (Farebrother et al. 1974).
When ERV is reduced, closing volume approaches or exceeds ERV so that
small airways may close within tidal breathing (Craig et al. 1971). Don et al.
(1971) have demonstrated regional gas trapping when CV was equal to or
greater than ERV. A further decrease in CV / ERV ratio has been observed in
supine position, and with age (Collins et al. 1973). Airways closure is an
important mechanism capable of impairing gas exchange (Craig et al. 1971,
Douglas et al. 1972). In early studies of Holley et al. (1967), a significant
pulmonary ventilation and perfusion abnormality was reported in obese
patients with low ERV (< 0.4 l or 21% predicted). The distribution of tidal
breathing in upright position was mainly to the upper lung zones, whereas
perfusion was maximal to the lung bases (Holley et al. 1967, Barrera et al.
1973). Farebrother et al. (1974) demonstrated that hypoxemia in obese patients
was related to the closure of dependent airways within the range of tidal
breathing.
Respiratory and airways resistance
Several studies have demonstrated the influence of lung volume on the
resistance of respiratory system (Rrs). With the reduction in lung volume
induced by different methods i.e. supine position or rib cage strapping,
increase in Rrs has been observed (Van Noord et al. 1986, Navajas et al. 1988,
Lorino et al. 1992). Zerah et al. (1993) showed increase in respiratory
resistance as well as in airways resistance (Raw) with increasing obesity. A
linear relationship was found between airways conductance (Gaw) and FRC.
The authors suggested that obesity is associated with an increased respiratory
resistance resulting from the reduction in lung volumes.
The dependence of pharyngeal area on lung volumes has been observed in
healthy subjects (Brown et al. 1986a). The dilating effect of lung inflation on
       REVIEW OF THE LITERATURE
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intrapulmonary airways has been established (Series et al. 1990). On the
contrary, pharyngeal size decreases with decreasing lung volumes (Brown et
al. 1986b). By this mechanism reduced FRC found in obesity may cause
pharyngeal narrowing contributing to increased airways resistance.
Oxygen cost of breathing and breathing pattern
Morbidly obese patients are known to have increased metabolic demands
because extra muscle work must be performed to move an obese body
(Dempsey et al. 1966, Luce 1980). Rates of total oxygen consumption (VO2)
and carbon dioxide production (VCO2) are increased even at rest in obesity
(Zavala et al. 1984, Refsum et al. 1990). To meet these increased
requirements, minute ventilation has to be increased. Minute ventilation at rest
is high in obese patients compared with normal subjects (Burki et al. 1984). To
maintain augmented ventilation, extra work has to be done because oxygen
cost of breathing is high in obesity (Kress et al. 1999). It has been assumed that
reduced chest wall compliance associated with the accumulation of fat
increases ventilatory load thereby increasing the work of breathing (Luce
1980). There are also several studies on respiratory muscle dysfunction in
obesity (Wadström et al. 1991, Weiner et al. 1998). Reduced chest wall
compliance in obesity or low lung volumes may cause inefficiency of
respiratory muscles (Luce 1980). Recently, Weiner et al. (1998) demonstrated
a significant improvement in respiratory muscle performance after weight loss
in patients with morbid obesity. The predominant change was improvement in
respiratory muscle endurance.
In non-obese persons oxygen cost of breathing (VO2RESP) as a percentage of
total body VO2 at rest is estimated to be less than 3% (Robertson et al. 1977).
Results of the study of Sharp et al. (1964b) suggested that obese subjects have
total respiratory work values up to twice normal. Kress et al. (1999) studied
the impact of morbid obesity on resting oxygen cost of breathing. The study
group consisted of 18 morbidly obese patients with the mean BMI of 53.4
(13.9) kg/m2. When VO2RESP / VO2 was assumed as 3% in normal subjects,
obese patients exhibited a fivefold increase in VO2RESP / VO2.
Tendency to rapid shallow breathing pattern has been observed in morbid
obesity (Kaufman et al. 1959, Salvadori et al. 1993). It has been assumed that
for a given VE, breathing with high frequency (BF) and lower tidal volume
(VT) may decrease oxygen cost of breathing (Luce 1980). However, with
           .
           .
    .
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    .                .
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increasing ventilation when BF rises and dead space (VD/VT) increases, rapid
breathing may become unfavorable (Misuri et al. 2000).
Increased ventilatory responsiveness to hypoxia has been observed in morbidly
obese patients who maintain adequate alveolar ventilation and are eucapneic
(Burki et al. 1984, Chapman et al. 1990, Babb et al. 1991). It is now well
recognized that in obesity hypoventilation syndrome (OHS), patients fail to
meet the increased demands for ventilation associated with obesity.
Ventilatory responsiveness to hypercapnia has been observed to decrease in
OHS (Rochester et al. 1974, Gold et al. 1993). There are studies suggesting
that this diminished responsiveness is acquired. Hypoventilation may be an
adaptive process sparing O2 for non-ventilatory demands (Luce 1980).
1.4. Weight loss and pulmonary function
The aim of the studies evaluating the effect of weight loss on pulmonary
function in obesity has been on one hand to demonstrate the effect of obesity
on pulmonary function and to clarify pathophysiological mechanisms behind
these disturbances. On the other hand respiratory complications increase the
risks of obesity and should be improved or abolished if the treatment of
obesity is regarded as effective. Most of the weight loss studies have been
made in patient groups with morbid obesity. Conservative treatment of morbid
obesity has demonstrated limited success and the maintenance of the weight
loss results have been poor  (Pekkarinen 1999, Mustajoki et al. 1999).
Therefore, morbidly obese patients are often candidates for surgical treatment
of obesity. However, patients may be reluctant to undergo surgery and all are
not eligible for surgery.
Very-low-calorie diet (VLCD) has appeared to be more effective than
conventional diets (Anderson et al. 1992). Combining VLCD with behavior
therapy (BT) has improved the long term maintenance (Pekkarinen et al. 1997,
Pekkarinen 1999). VLCDs are defined as diets that contain energy of 3.36 MJ
(800kcal) or less and high quality of protein 0.8-1.5 g/kg of ideal weight daily
(National Task Force 1993). The carbohydrate content is 50-100 g daily and
minerals, vitamins, electrolytes and essential fatty acids are according to the
Recommended Dietary Allowances. The patients drink a minimum of two
liters of non-caloric beverages daily (National Task Force 1993). Normally
VLCDs replace food for 4 to 16 weeks, followed by a structured refeeding
peruse. Side effects during VLCD are usually minor and transient. Weakness,
dizziness, constipation, dry skin, hair loss and cold intolerance may occur, but
         REVIEW OF THE LITERATURE
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when used for carefully selected patients under professional supervision
VLCDs are usually safe and effective. VLCDs are often combined with
behavior therapy.
According to National Institutes of Health Consensus Conference 1991
candidates for the surgical treatment of obesity are: patients with BMI > 40
kg/m2; BMI > 35 kg/m2 together with severe comorbidity; unsuccessful
conservative weight loss efforts; well motivated patients; commitment to a
long-term follow-up, and understanding the operative risks and eating
limitations after surgery. Gastric bypass (GBP) and vertical banded
gastroplasty (VBG) are the two procedures recommended for the treatment of
the severe to morbid obesity. They have turned out to be safe and effective in
long term.
Improvement in pulmonary function and gas exchange after weight loss
The most striking effect of weight loss in morbid obesity has been the increase
in lung volumes, particularly in ERV or FRC (Table 2). Several studies have
reported a significant increase in maximal voluntary ventilation (MVV) (Ray
et al. 1983, Refsum et al. 1990, Wadström et al. 1991). RV usually remains
unchanged, or only a slight increase has been observed. Consequently, changes
in FRC reflect changes in ERV. The improvement in oxygenation is assumed
to result from the increase in ERV. However, several studies have not been
able to show improvement in oxygenation despite a remarkable increase in
ERV. Farebrother et al. (1974) reported that improvement in PaO2 occurred if
the final weight was within 30% in excess of the ideal. Respiratory muscle
performance, i.e. muscle strength and endurance, improves with weight loss.
Weiner et al. (1998) studied morbidly obese patients before and six months
after bariatric surgery (VBG) (Table 2). Maximal inspiratory mouth pressure
(PImax) and expiratory pressure (PEmax) were measured as well as inspiratory
muscle endurance. The improvement in respiratory muscle performance
correlated with weight loss. Refsum et al. (1990) (Table 2) have studied the
effect of weight loss on ventilation and pulmonary gas exchange at rest.
Minute ventilation (VE) and resting metabolic rate (VO2) declined after weight
loss. VO2 related to body weight was low before weight loss and increased
with weight reduction. The change in VE was first of all due to a fall in tidal
volume (VT). This data gave no support to the concept that obesity leads to
rapid shallow breathing.
              .
     .
          .
    .
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Table 2. The effect of weight loss on pulmonary function and gas exchange
Study No Age Sex  Smoking Weight (kg) BMI (kg/m2) Weight loss  % Change Treatment
years F / M Before w.l  Before w.l (kg) from baseline
After w.l.                 After w.l.
Emirgil et al, 1973 4 26-48 2 / 2 - 155 (114-192) 49.1 (40.5-57.5) 49.1(28.1-68.0) ERV + 157 * Diet
106 (85-133) 33.7 (30.5-40.0) PaO2 + 7 ns
Farebrother at al, 1974 8 24-56 4 / 4 8 / 8 120 (107-143) 42.1 (36.5-45.7) 33.6 (18.1-74.8) ERV + 65 * Diet
86 (68-101) 30.9 (25.4-34.9) PaO2 + 11 ns
Vaughan et al, 1981 11 21-51 34 / 3 0 / 37 139 (4)SEM 50 (1)SEM 52 (2)SEM ERV + 71* Surgery
88 (5)SEM 31 (1)SEM PaO2 + 5 ns
Ray et al, 1983 29 19-32 21 / 8 - 160 (5) SEM 56.7 (1.8) SEM 54 ERV + 48 * Diet
106 (6) SEM 37.4 (2.1) SEM MVV + 10 *
Thomas et al, 1989 29 18-56 ? 14 / 29 126 (92-174) - 34.2 ERV + 54 * Surgery
TLC + 14 *
PaO2 + 23 *
Refsum et al, 1990 34 20-59 34 / 0 - 113.2 (84-156) 40.9 (33-50) 31.5 ERV + 71 * Surgery
81.7 (60-110) 29.7 (22-38) TLC +   6 *
MVV + 10 *
PaO2 +   6 *
VO2   - 23 *
VE - 17 *
VT - 10 *
Wadström et al, 1991 16 27-49 13 / 3 - 125 (17) 42.8 (6.2) FRC         + 16* Surgery
         TLC +   4*
MVV + 14 *
Weiner et al , 1998 21 25-52 - - 41.5 (1.3) SE ERV + 16 * Surgery
31.7 (1.1) SE RV + 11 *
TLC +   9 *
PImax + 23 *
PEmax + 15 *
* statistically significant
21
2. POSTURAL CHANGES IN RESPIRATORY FUNCTION
2.1. Normal subjects
Lung volumes are slightly but significantly higher in standing position
(Townsend et al. 1984, Appel et al. 1986). American Thoracic Society (1995)
and European guidelines (Quanjer et al. 1993) recommend that measurements
of lung volumes and forced ventilatory flows are made in seated upright body
position; other positions should be noted. In normal subjects there is a
reduction in FRC and an increase in airways resistance in response to changing
posture from sitting to supine. It has been assumed that most of this reduction
results from gravitational effects on the abdominal pressure (Moreno et al.
1961). Lung compliance decreases in supine body position probably reflecting
increased pulmonary blood volume and small airways closure (Behrakis et al.
1983). Body position can modify the generation of maximal inspiratory (PImax)
and expiratory (PEmax) pressures. Reductions in pressures have been observed
in response to change of posture from sitting to supine (Fiz et al. 1990 and
1991).
As early as forty years ago, Moreno et al. (1961) studied the effect of body
position on breathing pattern and O2 consumption in normal subjects. A
significant decrease in tidal volume was demonstrated when changing posture
from sitting to supine. The respiratory rate remained unchanged, while minute
ventilation decreased in supine position. A decrease in O2 consumption was
found in response to change of posture from sitting to supine. The relationship
of FRC to closing capacity (CV + RV) is an important determinant of airway
closure and consequent hypoxemia. The change of posture from sitting to
supine is associated with the decrease in FCR, CV may remain unchanged or
decrease only slightly (Don et al. 1971). In those subjects in whom this
decrease places FRC below CC, the volume of trapped gas increases (Don et
al. 1971).
Craig et al. (1971) examined the hypothesis that increase in CC above FRC
would result in a shunt-like effect and increase in alveolar arterial oxygen
difference P(A-a)O2. Measurements were done in sitting and supine positions
(Figure 3). In those subjects (1, in Figure 3) in whom CC did not exceed FRC
in either position P(A-a)O2 decreased in supine position. When closing
capacity occurred in the breathing range in supine position (2, in Figure 3)
P(A-a)O2 was elevated in this position.  As CC exceeded FRC in both
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positions (4, in Figure 3), P(A-a)O2 increased and was higher than in the other
groups. It changed only slightly with posture in this group. When subjects in
this study were grouped only according to age, weight, or smoking history, no
postural change in gas exchange was observed.
1. FRC > CC in both positions;                     3. CC < FRC +VT in sitting position &
                                                                           CC > FRC + VT in supine position
2. CC > FRC in supine position                     4. CC > FRC + VT
Figure 3. Relationship of closing capacity to tidal breathing (Craig et al. 1971).
                 VT = tidal volume  CC = closing capacity.
Closing capacity increases with age (Leblanc et al. 1970, Collins et al. 1973,
Estenne et al 1985). Leblanc et al. (1970) have reported that in normal subjects
CC exceeds FRC by about 40 years of age in the supine position, and by 65
years of age in the sitting position. These studies indicate the importance of
evaluating the results of blood gas analysis with reference to posture,
especially in elderly subjects.
2.2. Obesity
In obese subjects reduction in FRC and ERV measured in sitting position
would be expected to increase in supine position because of the cranial
movement of diaphragm that is enhanced by increased mass of abdomen. Yap
et al. (1995) failed to demonstrate any further fall in ERV in supine position.
  SITTING      SUPINE SITTING         SUPINE
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1
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In this study, however, ERV was very low both in supine and standing
positions when compared to control subjects in whom adoption of supine
posture caused a significant reduction in ERV.
There are few studies of respiratory compliance (Crs) in obese subjects.
Naimar and Cherniack (1960) found  reduced  Crs in seated obese subjects and
a small further fall when supine. The major component appeared to be the
changed chest wall properties in obesity. Respiratory resistance (Rrs) may be
increased in sitting position and may further increase in supine position (Yap
et al. 1995). The overall effect of supine body position on respiratory
mechanics in obesity seems to be the enhancement of changes found in sitting
position.
An early study of Farebrother et al. (1974) determined the effect of posture on
arterial oxygenation in obesity. Arterial oxygen tension (PaO2), ERV and
CV/VC were measured in sitting and supine positions. A significant reduction
in PaO2 was demonstrated in supine position. (ERV-CV)/VC% as well as ERV
alone were related to PaO2 both sitting and supine.
The effect of posture on O2 consumption has been studied in morbidly obese
patients (Paul et al. 1976). Change of posture from sitting to supine was
associated with the increase in O2 consumption. The authors suggested that
increased VO2 in the supine position reflects increased work of breathing.
Small airway closure and increased congestion of the lungs in supine position
may increase airway resistance and decrease pulmonary compliance.
3. OBSTRUCTIVE SLEEP APNEA AND OBESITY
Obesity is considered as a major risk factor for the obstructive sleep apnea
syndrome (OSAS) (Guilleminault et al.1988, Douglas et al. 1994, Strobel et al.
1996). Although a close association between obesity and OSAS has been
observed in clinical and epidemiological studies, the causal relationship
between obesity and OSAS has been difficult to prove. Several mechanisms
have been proposed including alterations in upper airways structure and
function, changes in ventilatory drive, and obesity induced hypoxemia or
abnormalities in pulmonary function (Appelberg et al. 2000)(Figure 4). In
addition, there are recent studies referring to indirect mechanisms connecting
obesity and OSAS. The development of OSAS has been reported to relate to
the profile of body fat distribution. Shinohara et al. (1997) reported that
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visceral obesity is a risk indicator for OSAS in obese subjects. Conversely,
treatment of OSAS by nasal continuous positive airway pressure (nCPAP)
reduced visceral fat accumulation and leptin levels (Chin et al. 1999,
Saarelainen et al.1997, Ip et al. 2000). Recently, Marik (2000) proposed that
both obesity and OSAS could be due to leptin resistance. Ip et al. (2000)
demonstrated that obese subjects with OSAS have significantly higher levels
of leptin than weight-matched controls. NCPAP could restore leptin receptor
sensitivity  (Marik 2000).
Figure 4.  The relationship
between obesity and OSAS.
Modified from Strobel et al.
(1996).
3.1. The effect of obesity on upper airways (UA) structure and function in
OSAS
Obesity and deposition of fat may alter upper airways structure. The increase
in size of upper airways soft tissue structures has been demonstrated with
increasing obesity (Partinen et al. 1988, Horner et al. 1989). Recently, results
of two cephalometric studies in OSAS patients (Brander et al. 1999 and
Sakakibara et al. 1999) confirmed that the main difference in upper airways
size between obese and non-obese subject is the enlargement of upper airway
soft tissue. In addition to alterations in UA structure, differences in UA
function have been observed in patients with OSAS. It has been assumed that
fat surrounding UA may alter soft tissue properties more compliant or fat
infiltrating UA muscles may interfere with their function increasing
collapsibility of the pharynx (Suratt et al. 1985). Reduced lung volumes
associated with obesity may also decrease UA size or make the pharynx more
susceptible to collapse. The patency of the upper airways is influenced by lung
volume. The cross sectional area of the upper airways decreases as lung
Abdominal and
chest wall fatPharyngeal fat
UA compliance
UA caliber
OBESITY
Lung volumes
UA collapsibility OSAS
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volume decreases from total lung capacity to residual volume (Hoffstein et al.
1984, Strobel et al. 1996). Similarly the upper airways resistance varies with
lung volumes, the lower the lung volumes the higher the resistance (Series et
al. 1990). The results of animal studies suggest that tracheal traction may
decrease pharyngeal resistance (Van de Graaff  1988).
May obstructive sleep apnea then be reversed by increase in lung volumes?
Brown et al. (1986b) and Series et al. (1988 and 1989a) have studied the effect
of pulmonary inflation on sleep apnea and oxygen saturation. They reported
that the increase in FRC induced a significant reduction in rate and depth of
the fall in SaO2. Through the increase in lung volume weight loss may affect
pharyngeal  geometry and function.
3.2. Obesity induced hypoxemia in OSAS
Obesity induced hypoxemia may increase ventilatory instability which may
facilitate UA occlusion (Strobel et al. 1996). Supporting this finding Onal et al.
(1982) observed that genioglossus activity decreased with decreasing
ventilation during periodic breathing. Supplemental oxygen may have
beneficial effects on ventilatory stability. In obese patients with OSAS and
hypoxemia, supplemental oxygen reduces mean apnea index and time (Martin
et al. 1982, Smith et al. 1984, Gold et al. 1985). It is controversial whether
OSAS may cause pulmonary hypertension without hypoxemic lung disease.
Recently, Sajkov et al. (1999) reported that some patients with OSAS may
develop pulmonary hypertension without lung disease and its development was
associated with small airway closure during tidal breathing.
3.3. Obesity and ventilatory responsiveness in OSAS
Ventilatory load compensation is defined as a sufficient ability to maintain
adequate ventilatory output despite a mechanical hindrance to breathing.
Imbalance between mass loading and central ventilatory drive in obese patients
with OSAS has been observed (Strobel et al. 1996, Hudgel et al. 1998). A
reduction in central respiratory drive coupled with increased elastic loading
has been demonstrated in obesity-hypoventilation syndrome (Rochester et al.
1974). Similar abnormalities have been observed in eucapnic patients with
OSAS (Gold et al. 1993). Sleep apnea patients had lower hypercapnic
ventilatory response and higher waking PaCO2 compared with normal obese
controls (Burki et al. 1984, Gold et al. 1993). It is possible, that disturbances in
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ventilatory control in obese sleep apnea patients are a continuum from normal
obesity to the pickwickian syndrome (Gold et al. 1993).
3.4.  The effect of posture on OSAS
The upper airways resistance in OSAS decreases while moving from the lying
to the sitting position (Anch et al. 1982). Body position during sleep affects the
frequency and severity of breathing abnormalities in OSAS patients
(Oksenberg et al. 1997). It has been demonstrated that a sitting sleep posture
(60-degree angle) abolished obstructive sleep apnea in some patients without
simultaneous disturbance in sleep architecture (McEvoy et al. 1986). The
effect was most pronounced in patients with marked obesity and hypoxemia.
The mechanisms proposed were the effects of posture on upper airways and
improved oxygenation with increasing FRC in sitting position. Neill et al.
(1997) reported that in patients with severe OSAS the elevation of upper body
to 30 degree improved upper airways stability during sleep better than lateral
positioning.
3.5. Treatment of OSAS and daytime oxygenation
Treatment of OSAS with nasal CPAP may improve daytime oxygenation in
patients with OSAS (Sforza et al. 1990, Leech et al. 1992). The improvement
in PaO2 has been more pronounced in patients who were hypoxemic prior to
treatment (Sforza et al. 1990). In OSAS patients with hypercapnia a significant
improvement in blood gas values has been demonstrated with nocturnal nasal
positive pressure ventilation (NIPPV), but not on CPAP (Piper et al. 1994). In
obese patients with OSAS a significant improvement in daytime oxygenation
after dietary induced weight loss has been demonstrated (Suratt et al. 1992).
 3.6. The effect of weight loss on OSAS
Over the past decade several studies have been conducted on the effects of
surgical and dietary weight loss in patients with OSAS (Strobel et al. 1996). A
consistent trend has been observed towards improvement in sleep disordered
breathing (SDB) (Smith et al. 1985, Sugerman et al. 1986, Suratt et al. 1987,
Pasquali et al. 1990, Rajala et al. 1991, Lojander et al. 1998, Kansanen et al.
1998).  The amount of weight loss needed to achieve significant improvement
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in SDB is not clear. Another issue not resolved has been the poor long term
maintenance of weight loss results.
4. ASTHMA
4.1  Mechanical factors regulating airway caliber
Asthma is associated with a variable airflow limitation and airway closure. In
addition to reversible airway obstruction some individuals with chronic asthma
may show an irreversible component of airflow obstruction. The mechanisms
leading to this fixed airflow limitation are unknown. It may be associated with
structural changes in the airways resulting from inflammation in the airways
(Fabbri et al. 1998).
In obesity,  narrowing of the airway lumen that is responsive to
bronchodilators has been reported (Unger et al. 1990, Fredberg et al. 1997). To
evaluate the impact of obesity on airway narrowing and bronchial
responsiveness in obese patients with chronic asthma, it is important to deal
with the pathophysiological mechanisms of airway narrowing. Forces that tend
to contract the airways and those that prevent narrowing determine the caliber
of the intrathoracic airways (Fredberg et al. 1997). When a contractile stimulus
is applied to the airway smooth muscle, the airway lumen decreases depending
on how much the airway smooth muscle shortens and on the thickness of
airway wall (Figure 5) (Brusasco et al. 1999).
Figure 5. Mechanical factors regulating airway caliber. + : mechanism increasing a
given effect;   - : mechanism decreasing a given effect. Modified from Brusasco et al.
(1999).
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The maximum extent to which smooth muscle can shorten is determined by
the force developed by smooth muscle and by the magnitude of opposing
factors. In asthma the airway smooth muscle may be thicker than normal.
Assuming that muscle hypertrophy and hyperplasia are associated with an
increased capacity to generate force, increased thickness of airway smooth
muscle layer may be the major determinant of airway narrowing in asthma
(Lambert et al. 1994). On the other hand abnormalities of smooth muscle
contractility may contribute to the increased airway narrowing in asthma. The
forces opposing airway narrowing include elastic elements of the airway
(internal load) and of the surrounding lung parenchyma (external load). The
magnitude of internal load depends on the stiffness of the airway wall as well
as on the changes in geometric configuration that airway mucosa undergoes
upon airway smooth muscle shortening. The thickening of the basement
membrane in asthma may increase load on airway smooth muscle, thus
opposing airway narrowing (Lambert 1991).
Mucosal folding provides a further load to smooth muscle (Lambert et al.
1994). Modelling studies have shown that the greater the number of folds, the
less the obstruction (Lambert et al. 1994). However, the number of folds may
decrease when mucosa is thick (Wiggs et al. 1997). In this regard, basement
membrane thickening may increase airway narrowing. The external load the
airway smooth muscle of intraparenchymal airways has to overcome during
shortening, includes lung elastic recoil and forces of interdependence between
airways and lung parenchyma (Macklem 1996). As lung elastic recoil pressure
changes with lung volume, airway narrowing induced by constrictor agents is
expected to be less at high than at low lung volumes (Ding et al. 1987). The
interdependence between airways and lung parenchyma is produced by the
parenchymal attachments to the airway external wall. The forces of
interdependence tend to make the airways follow the movements of the lung.
4.2. Small airway disease in asthma
Every part of the airways can be involved in asthma. Thus airway narrowing in
asthma may occur in both central and peripheral airways. The same individual
may show evidence of predominantly central obstruction on one occasion and
mainly peripheral obstruction on another (Pride et al. 1986). The small
airways, defined as those airways of less than 2 mm internal diameter, provide
a far greater cross-sectional area for airflow than the large airways. It is
generally considered that the resistance in the small peripheral airways of the
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lung constitutes less than 20% of the total airways resistance (Macklem 1998).
In clinical practice, the changes in function of the small airways are difficult to
demonstrate (Evans et al. 1998). Expiratory flows measured at low lung
volumes (MEF50,MEF, FEF25-75), i.e. in the terminal part of forced expiration,
have been regarded as a measure of peripheral airway narrowing. As a measure
of airway size related to lung size FEF25-75 / FVC has been used (Litonjua et al.
1999).
However, the flow at low lung volumes is not a specific or sensitive measure
for detecting peripheral airways obstruction. A concave flow -volume curve
and low flow rates during the last part of the volume can be considered as a
profile of narrowing of small airways if the elastic recoil of the lungs and
airways resistance (excluding narrowing of the large airways) are normal
(Cherniack 1995).  In asthma the involvement of the large airways can make it
difficult to evaluate the narrowing of the small airways from the tests of forced
expiration.
4.3. Lung volumes
The alterations in airway mechanics occurring in asthma, particularly airway
closure, may affect lung volumes. The early studies have shown that asthma is
often characterized by a reduction in VC and increased residual volume (RV).
These changes reflect increased air trapping, which results from closure of the
airways (Woolcock et al. 1971). Airway closure may occur with airways
smooth muscle contraction as well as occlusion of the airways by mucus, or
mucosal thickening (Roche 1998).
FRC is also increased in patients with asthma for several reasons. Because the
static volume-pressure curve is shifted upward and to the left in asthma,
equilibrium between the elastic recoil of the chest wall and that of the lungs
occurs at a higher lung volume (Cherniack 1995). Also, the increased
inspiratory muscle activity is regarded as an important cause of increased FRC.
Activation of inspiratory muscles effectively brakes the expiration and causes
the end-expiratory lung volume to increase (Cornier et al. 1990). Finally, FRC
is likely to be elevated because the increased flow resistance prolongs the
overall time constant of the respiratory system, so that the time available for
the lung to deflate is inadequate and equilibrium between the elastic forces is
not achieved (Cherniack 1995). Because the flow resistance depends on the
size of the airways, it is influenced by the lung volume and the lung elastic
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recoil pressure. Thus, a correction must be made for the lung volume at which
resistance (Raw) is measured. The relationship between lung volume and
airways resistance is almost parabolic, but the reciprocal of Raw, which is
called airways conductance (Gaw) is linearly related to lung volume.
Measurements of Raw or SGaw predominantly reflect the resistance to airflow
in the larger airways.
4.4. Peak flow variability
Exaggeration of the endogenous cicardian variation of airways patency is a
particular feature of asthma. Other pulmonary function measures, specifically
FEV1 and airways resistance (Raw) show strong cicardian patterns with lowest
periods nocturnally, but PEF has the strongest cicardian rhythm (Lebowitz et
al. 1997). Related biochemical cycles include plasma histamine maxima and
plasma cyclic adenosine monophosphate (cAMP) and epinephrine minima
when PEF is at its minimum. The nocturnal reduction in function in asthma is
related to bronchial responsiveness. Inflammation is closely related to the
bronchial responsiveness. Broncho alveolar lavage have shown nocturnal
increase in inflammatory cells in asthmatic with the nocturnal worsening
(Martin et al. 1991). The fall in PEF was correlated with the cellular changes.
Diurnal variability of PEF has been used as a marker of airway responsiveness,
particularly in epidemiological studies. Daily PEF variation has been reported
to correlate with the severity of bronchial hyperreactivity (BHR) (Brand et al.
1991, Higgins et al. 1993, Boezen et al. 1996, Kolbe et al. 1996). Yet, there are
studies suggesting that PEF variability and BHR reflect different
pathophysiological mechanisms (Boezen et al. 1998). In children, diurnal PEF
variation correlated with exercise-induced bronchoconstriction but not with
histamine or metacholine challenges (Sekerel et al. 1997).
Several alternative equations may be used to express PEF variation. The most
common for diurnal PEF variability are the amplitude percentage mean
(( maximum - minimum)/mean) or the amplitude percentage maximum
(maximum-  minimum)/maximum), calculated for each day, and then averaged
over a period of 1 or 2 weeks. Standard deviation (SD) percent mean morning
PEF or coefficient of variation is generally used to express day-to-day PEF
variability. For normal clinical practice these calculations are regarded as too
time consuming. Recently, a simpler index of PEF variation such as the lowest
morning peak flow, expressed as percentage of the patients personal best PEF,
has been introduced to be included in new asthma guide lines (Reddel et al.
       REVIEW OF THE LITERATURE
31
1999).  As nine different PEF indices were evaluated, minimum morning PEF
(expressed as percent recent best PEF) was recommended as the best index of
airway lability  in patients with stable asthma. It correlated strongly with BHR
(Reddel et al. 1995).
4.5. Airway size and bronchial hyperresponsiveness
It has been suggested that the factors that can increase airway wall thickness or
reduce airways size could influence airways responsiveness (Wiggs et al.
1992). Moreno et al. (1986) have suggested that with the increase in airway
wall thickness the reactivity may increase with a modest or even without any
increase in airways resistance. This is supported by studies reporting increased
airways responsiveness in subjects with heart failure (Cabanes et al. 1989). It
is possible that airway size also affects airway responsiveness (Brusasco et al.
1998 and 1999). Brusasco et al. (1998) reviewed studies on airway
inflammation and airway hyperresponsiveness in asthma. The authors
concluded that airway hyperresponsiveness and airway narrowing in asthma
are not just a matter of airway inflammation. Boulet et al. (1995) have studied
the relationship between bronchial wall thickness and airway responsiveness.
Correlation between wall thickness and airway responsiveness was
demonstrated only in asthmatic patients with fixed airway obstruction.
Bronchial diameter correlated with bronchial reactivity in normal subjects but
not in asthmatics. They suggested that in asthmatics other factors than airway
narrowing may be more significant in determining the degree of airway
responsiveness.
5. ASTHMA AND OBESITY
The rise in asthma prevalence in children and adults has been accompanied by
an increase in the prevalence of obesity. Increasing epidemiological evidence
suggests that there is an association between obesity and asthma (Gennuso et
al. 1998, Luder et al. 1998, Camargo et al. 1999, Shaheen et al. 1999a).
However, the nature of the association needs to be clarified (Shaheen 1999b,
Wilson et al. 1999). At present it is not possible to say whether obesity has
contributed to the rise in asthma prevalence. The direction of the association is
difficult to determine from cross-sectional studies.
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5.1. Association between asthma and obesity
Population based cross-sectional studies have found positive associations
between BMI and wheeze or asthma in children (Gennuso et al. 1998, Huang
et al. 1999). Luder et al. (1998) have reported that children with moderate to
severe asthma  are more likely to be obese than their controls from the same
environment. An association between obesity and asthma symptoms was also
demonstrated. In the large Nurses’ Health Study II in the USA, a strong
positive association between BMI and risk of adult-onset asthma was observed
in women aged 27-44, who were followed for four years (Camargo et al.
1999). Again, the prevalence of asthma increased with increasing body mass
index in females aged 12-24 years but not in males according to the Canadian
National Population Health Survey in 1994-1995 (Chen et al. 1999). In a
British Cohort Study (BCS70) BMI was associated with the prevalence of
asthma at 26 years of age (Shaheen et al. 1999a). The results of the study
suggested that impaired fetal growth as well as adult obesity were risk factors
for adult asthma. Dixon et al. (1999) reported a high prevalence of asthma
(24.6%) among morbidly obese adults, compared to overall prevalence of 12-
13% in Australian community.
Is this association a real one?  Firstly, a low level of physical activity, which is
clearly associated with higher BMI (Gortmacher et al. 1996), was not taken
into account in all these studies. Low physical activity with reduction in deep
breathing may lead to airway narrowing by reducing the extent to which
bronchial muscle is stretched (Platts-Mills et al. 1997, Shaheen et al. 1999a).
In the abcence of deep inspirations healthy persons may develop broncho-
constriction with methacoline inhalation (Skloot et al. 1995). Recently,
Kapsali et al.  (2000) demonstrated that deep inspiration with lung inflation
has a potent bronchoprotective effect in normal healthy subjects but not in
patients with asthma. Secondly, the dietary factors may explain the association
between asthma and obesity. For example, salt intake and a low intake of
antioxidants are proposed as risk factors for asthma (Weiss 1997). Thirdly,
there may exist humoral and physiologic effects between asthma and obesity.
For example, obesity increases gastroesophageal reflux (Wilson et al.1999),
which may trigger latent asthma.  Varner (2000) proposed immunologic
mechanisms based on biological activity of adipose tissue. Production of
interleukin 6 (Mohamed-Ali et al. 1997) and cyclooxygeanse-2 (Williams et al.
1997) from human adipose tissue may increase the risk of asthmatic
inflammation. Recently the association between polymorphism in the human
beta2-adrenoceptor gene and obesity has been reported in French men
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(Meirhaeghe et al. 2000). At present there are many questions that remain to be
answered.
5.2. Weight loss in obese asthmatics
In morbid obesity a significant improvement in asthma has been observed after
surgical weight loss (Dixon et al. 1999). The effect of weight loss on asthma
was evaluated by using a questionnaire about the effects of asthma on sleep,
exercise, asthma treatment required, and admissions to hospital due to asthma.
The asthma score decreased significantly with weight reduction. The authors
suggested that mechanisms other than direct weight loss including prevention
of gastroesophageal reflux may play a part in this improvement.
Recently, a significant increase in FEV1 and FVC as well as decrease in
symptoms was demonstrated in obese asthmatics after dietary induced weight
loss (Stenius-Aarniala et al. 2000). During weight reduction program, no
changes in serum or urine cortisol or urinary excretion  were observed. The
one year maintenance of weight loss results and improvement in lung function
was good.
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AIMS OF THE STUDY
The purpose of this study was to evaluate the effects of obesity on pulmonary
function with special reference to asthmatics and patients with obstructive
sleep apnea. The specific aims were:
1. To study the effectiveness of very-low-calorie-diet (VLCD) in improving
pulmonary mechanics and gas exchange at rest and during exercise in morbid
obesity
2. To evaluate the effects of weight loss and body position on daytime lung
function and arterial oxygenation in obese patients with obstructive sleep
apnea
3. To study the relation between asthma and obesity by comparing changes in
peak flow variability and airways obstruction in response to weight reduction
with simultaneous changes in lung volumes in obese asthmatics
4. To investigate the effects of weight reduction and body position on
breathing pattern and gas exchange in obese asthmatics
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PATIENTS AND METHODS
1. Patients
The anthropometric and lung function data as well as the diagnoses of the
patient groups are given in Table 3.
Study I
The study population in Study I consisted of patients with morbid obesity
(BMI > 40 kg/m2) who were referred to the Metabolic Unit of Helsinki
University Central Hospital for conservative treatment of obesity. They were
initially examined by an endocrinologist. The criteria for referral to the
University clinic were body mass index greater than 40 kg/m2 and age less
than 60 years. The weight reduction program included a very-low-calorie diet
period combined with behavior therapy modification. Among the patients
enrolled to start the weight reduction program 15 consecutive patients were
selected to participate this study. Patients with a history of obstructive sleep
apnea, obstructive lung disease or other serious illness were excluded. Current
smokers were not included. Ex-smokers were included only if they had quit
smoking at least two years earlier. Four patients dropped out the weight
reduction program. Thus the study population consisted of 11 patients. The
baseline pulmonary function and body fat distribution data presented in Table
6 include results of all 15 patients who started the study. This data has not
been published before.
Study II
Seven patients from study I who had lost weight at least 10 kg (n = 7) were
selected for further evaluation. Exercise testing with continuous analysis of
expired air and arterial blood sampling was carried out. The mean weight loss
in this study group had been 25.7 kg (range 10 to 50 kg).
Study III
Thirteen obese patients with obstructive sleep apnea were studied. The study
population consisted of patients who were referred to the Helsinki University
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Table 3.   Diagnoses, anthropometric and lung function data of the study populations. Values are means (SD).
Age Sex Weight BMI FEV1 FVC FRC Raw
(years) F/M (kg) (kg/m2) (% pred) (% pred) (% pred) (% pred)
Study I
Morbid obesity  (N = 11) 40.7 (8.2) 6/5 133 (24) 45.4 (5.8) 95 (10) 101 (15) 65 (20)  201 (88)
Study II
Morbid obesity  (N = 7) 44.1 (7.5) 3/4 140 (22) 46.6 (6.3) 96 (17) 90 (9) 70 (24)  197 (102)
Study III
OSAS (N = 13) 48.8 (8.8) 1/12 109 (10) 35.2 (2.5) 101 (7.3) 96 (7.3) 71 (7) 149 (30)
Study IV
Asthma (N = 14) 51.8 (9.1) 11/3 101 (14) 37.2 (3.7) 77 (14) 88 (13) 86 (21) 329 (166)
Study V
Asthma (N = 14) 51.8 (9.1) 11/3 101 (14) 37.2 (3.7) 77 (14) 88 (13) 86 (21) 329 (166)
Healthy controls (N = 11) 35.6 (11) 8/3 68 (12) 22.4 (2.6) 110 (14) 109 (10)
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Central Hospital due to symptoms suggestive of obstructive sleep apnea,
excessive daytime somnolence and snoring, being the most common. The
diagnosis of OSAS was based on oximetry with the static-charge-sensitive bed
method validated previously (Svanborg et al. 1990).  Moderately to severely
obese patients (BMI 30-40 kg/m2) were evaluated for the weight reduction
program. Patients who were at risk from somnolence at work, e.g. lorry drivers
were excluded. Further exclusion criteria included asthma and chronic
obstructive pulmonary disease, unstable angina pectoris and symptomatic liver
or biliary disease. Altogether 61 patients with OSAS (mean age 49 years; mean
BMI 32 kg/m2) were evaluated at the outpatients’ department of pulmonary
medicine, as described by Lojander et al. 1998. Current smokers were
excluded from our study. The study population consisted of the first thirteen
OSAS patients who started the weight reduction program.
Study IV
The study population consisted of fourteen obese asthmatics. They were
selected from the 19 patients who participated as a control group in the study
of Stenius-Aarniala et al. (2000). The recruitment of the patients to that study
has been described elsewhere (Stenius-Aarniala et al. 2000). The control
patient group took part in educational sessions concerning asthma and allergy
and their spirometric and serial PEF values were carefully followed up every
two months during one year. Two to five months after closing that trial, 14
obese asthmatics out of 19 patients volunteered to start the weight reduction
program including a 8-week VLCD period. Current smokers were excluded. 4
of 14 patients were ex-smokers with the mean smoking history of 12 pack
years. The diffusing capacity was within normal range in all patients. The
mean duration of asthma was 12.7 years (range 1 to 27 years). The anti-
asthmatic medication included regular use of inhaled corticosteroids in all 14
patients, sustained-release theophylline compounds in 2 patients and regular
long-acting beta2 -agonists in 3 patients.
Study V
The study population consisted of fourteen obese asthmatics and eleven
healthy control subjects. The obese patients with asthma are the same as in
Study IV. Eleven healthy non-obese (BMI< 27 kg/m2) non-smoking subjects
without any cardiorespiratory symptoms or signs were volunteered as controls.
They all showed normal findings in physical examination and in flow volume
spirometry.
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2. Methods
Pulmonary  function tests
Flow- volume spirometry was performed using a rolling seal spirometer (CPI
220, Cardiopulmonary Instruments, Houston, USA) connected to a
microcomputer system (Medikro 202, Medikro Oy, Kuopio, Finland). The
results from the envelope curve of at least three forced expiratory flow-volume
loops were recorded. The highest values of forced expiratory volume in one
second (FEV1) and forced vital capacity (FVC) were determined with the
patient in the sitting position (Study I-V). In Study III flow rate at a volume of
50% of FVC (MEF50) and in Study IV flow rate at the middle part of FVC
(FEF25-75) as well as area under the expiratory flow volume curve (AFV) were
reported. The peak inspiratory flow (PIF), forced inspiratory volume in one
second (FIV1) and forced inspiratory vital capacity (FIVC) were recorded in
Study III. Maximal voluntary ventilation (MVV) was measured from a period
of 15 s of maximal breathing to the spirometer (Study I).
A single breath method (Master Lab, Jaeger, Wurtzburg, Germany) was used
for measuring diffusing capacity of the lungs for carbon monoxide (DLco) in
Studies I, III and IV. Lung volumes were determined using a single breath
helium dilution method (VCHe, TLCHe and FRCHe) and body plethysmograph
(VCB, RVB, TLCB and FRCB). The evaluation of non-ventilated lung
compartment was based on the difference between TLCB and TLCHe  (Study I
and IV). Airways resistance (Raw) as well as airways conductance (SGaw)
were measured during tidal breathing timed with a metronome (30/min) using
a constant volume body plethysmograph (Bodyscreen, Erich Jaeger GmbH,
Wurtzburg, Germany). The mean value of 3-5 determinations was recorded for
analysis. ERVB  was calculated from the difference between  FRCB-RVB.
In Study I closing volume CV was measured with the patients in sitting
position by using a nitrogen single breath method (Buist et al. 1973). At least
three measurements were performed; the mean value was recorded for the
analysis. Closing capacity CC was then calculated as CC = CV+RVB. In Study
III  closing volume was measured with the patient in supine and sitting
positions. Otherwise the method used was identical with the one described
above.
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Arterial blood gases
A brachial or a radial artery was cannulated for arterial blood samples in
Studies I-II. After the cannulation patients rested at least for 10 min in supine
position.  That was followed by an orthostatic tolerance test lasting for 8 min
according to Thulesius (1970). Arterial blood samples for blood gas analysis
were drawn in supine position and during orthostatic tolerance test in standing
position at 8 min. In Study II arterial blood samples were also drawn during
exercise testing at the end of each work load, at the peak exercise, and 10 min
following the exercise phase. Arterial blood PaO2, PaCO2, pH, and base excess
were analyzed using an automatic acid-base analyzer (ABL 30, Radiometer,
Copenhagen, Denmark). Alveolar-arterial oxygen tension difference was
obtained from the following equation:
P(A-a)O2 = PAO2 - PaO2 ;
PAO2 = FiO2 x (PB - PH2O) - PaCO2
     
 RQ
where PB is the actual barometric pressure, PH2O is water vapor tension at 37oC,
FiO2 is oxygen content of inspired air and RQ the respiratory quotient
(VCO2/VO2) assumed to be 0.8 at rest. In study II actual measured RQ values
during exercise were used for calculations.
Exercise test with respiratory and blood gas analyses
In Study II, before orthostatic and exercise testing, a brachial or radial artery
was cannulated under local anaesthesia. After 10 min rest in supine position an
orthostatic tolerance test described above (Thulesius 1970) was carried out.
This was immediately followed by exercise test using an electrically braked
bicycle ergometer (Bosch ERG 220, Robert Bosch GmbH, Berlin, Germany)
with the patient in sitting position. The initial work load was 40 W for women
and 50 for men. It was then increased at 3 min intervals in steps of 40 W and
50 W, respectively, until exhaustion (grade 19-20 according to Borg 1962). A
twelve lead (Mason-Likar) electro-cardiogram (ECG) was continuously
monitored and recorded during the test using a computerized ECG device
(Marquette, Case12, Marquette Inc, USA). Blood pressure was measured
stethoscopically by a sphygmomanometer (Erkanieter, Germany) from the left
arm.
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For the collection of respiratory gases a tightly attached face mask (Rudolph
series 7910, Hans Rudolph Inc,  Kansas City, USA) with a dead space of 185
ml was used. Continuous measurement of minute ventilation (VE), oxygen and
carbon dioxide partial pressures of the mixed expired air was carried out and
the ventilatory variables (all in BTPS) were calculated at 30 s intervals using a
microcomputer assisted equipment (Ergo-Oxyscreen, Erich Jaeger GmbH,
Wurzburg, Germany). Minute ventilation (VE), breathing frequency (BF),
oxygen consumption (VO2), carbon dioxide outflow (VCO2), respiratory
exchange reatio (RQ), ventilatory equivalent for O2 (VE/VO2) and for CO2
(VE/VCO2), and end expiratory tidal CO2 fraction (FETCO2) were recorded.
Breathing reserve was defined as (MVV - peakVE) x 100/MVV, where MVV
represents maximal voluntary ventilation. O2-pulse (VO2 related to heart rate,
VO2/ HR) was also calculated.
Orthostatic test with respiratory gas analyses
In Studies III and V, respiratory gas exchange and ECG (HR) were
continuously monitored during orthostatic tolerance test (Thulesius 1970). The
method used for collection and analyses of respiratory gases was identical to
that used during exercise testing (Study II). After the patient had rested for 10
minutes in supine position, respiratory gas exchange was monitored for ten
minutes in supine position. Steady state ventilation was achieved within five
minutes. The initial five minutes of data were discarded and data from
subsequent five minutes were used for calculation of ventilatory gas exchange
variables as in Study II. After this resting period, patients were asked to rise up
and stand still and unsupported for 8 minutes. Gas exchange and ventilation
were continuously monitored during standing. The data from the last five
minutes were used for calculations as in supine position.
Sleep studies
In Study III the diagnosis and follow-up of OSAS was based on oximetry with
the static-charge-sensitive bed method (Svanborg et al. 1990). Transcutaneous
arterial oxygen saturation was continuously monitored with a Biox 3700e
Pulse oximeter using a finger probe (Ohmeda, Boulder, Colorado, USA).
Airflow through the nose and mouth were monitored by thermistors.
Respiratory and body movements were recorded with a SCSB methods (Bio-
matt, Biorec Inc., Finland) (Salmi et al. 1989). The frequency of oxygen
desaturation events (ODI4 = desaturation by 4% or more per our in bed and
ODI10 = desaturation by 10% or more, respectively) was calculated to
    .
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characterize the amount of respiratory disturbances during the night. ODI4
indices of greater than 10 were considered abnormal. Daytime somnolence was
recorded on a 100 mm linear visual analogue scale, where 0 represented
”none” and 100 mm ”very severe”.
Peak expiratory flow variability
The highest of three measurements of peak expiratory flow (PEF) by mini-
Wright peak flow meter was recorded by the patients themselves every
morning and evening during 14 successive days before and after the weight
loss period. If patients were taking bronchodilator, PEF values were measured
before its use. PEF variability was expressed in three ways:  as the diurnal PEF
variation (highest PEF - lowest PEF / mean value of the two, x 100%), the
mean difference between the highest and lowest morning PEF values measured
over a follow-up period of 14 days, and the day-to-day PEF variation (SD
percent mean morning PEF).
Histamine challenge
A rapid dosimetric method with controlled tidal breathing was used for
histamine challenge of the airways (Sovijärvi et al. 1993). Patients with a
FEV1  <  70 % predicted were excluded from histamine provocation testing .  If
FEV1  decreased from the baseline by 15 percent or more after any dose,
further administration of histamine was discontinued. The PD15FEV1 was
calculated from logarithmically transformed histamine doses.
3. Study designs
Study I-II
In Studies I and II patients with severe to morbid obesity were treated with
weight reduction program that included VLCD period for 6 weeks and
behavioral therapy (BT) for 16 weeks (Pekkarinen et al. 1999). VLCD period
started before group BT. The VLCD used was Dietta Mini (MediFood,
Finland). It provided 2100 kJ daily and consisted of 50g high-quality protein,
65g of carbohydrate, and 2g of fat, and vitamins, trace elements, and minerals
according to the recommended dietary allowances. It was in powdered form
and mixed with water. A moderate amount of low-energy vegetables was
allowed during the VLCD period. The 16-week behavior therapy program had
been developed in the Metabolic Unit of the Department of Medicine in
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Helsinki University Hospital (Pekkarinen et al. 1997) and was partly based on
the LEARN Program for Weight Control by Brownell (Brownell 1985). The
16-week-program consisted of weekly group sessions that lasted for 1 hour and
were led by a trained nurse. Issues discussed in sessions included recording of
eating behavior, control of eating stimuli, slowing of eating rate, planning
ahead, eating in only one place, discussions of the energy and nutrient content
of foods and low-energy shopping and cooking. VLCD and BT program lasted
for 5 months. Pulmonary function tests and exercise testing were done before
and after VLCD+BT program. Six to eight months after the start of the weight
reduction program the lung function tests were repeated. This was also the end
point of the weight loss in this study. Pulmonary function tests were done in
sitting position. In order to study the postural changes in pulmonary gas
exchange, arterial blood gases were measured in supine and standing positions
before and after weight reduction.
Study III
The weight reduction program consisted of VLCD for the first 6 weeks. The
VLCD used was Dietta Mini as in Studies I-II.  Prior to the 6-week VLCD
period and after that patients were weighed. Overnight polygraphic recording,
VAS, pulmonary function tests and arterial blood gas analyses were carried out
before starting VLCD and six weeks later at the end of VLCD. Arterial blood
samples for blood gas analysis were taken in supine and standing positions.
Alveolar-arterial oxygen tension differences were calculated in both body
positions. Closing volume was measured in supine and sitting positions. Other
pulmonary function tests were done with the patients in sitting position.
Studies IV- V
All patients participated in a weight reduction program starting with a VLCD
period of eight weeks. The VLCD preparation used was Nutrilett (Nycomed
Pharma AS, Oslo, Norway). The daily dose was five sachets that contains 429
kcal/1760 kJ of energy, 60g of protein, 7g of fat, 30,5 g of carbohydrate of
which 17.5 g is fiber. The VLCD preparation is in powder form and is mixed
with water. In addition to the powder preparation, the VLCD includes one
daily tablet containing the recommended daily amounts of vitamins, minerals
and trace elements and one capsule containing essential fatty acids. The end
point of weight reduction was the time of repeating lung function tests and gas
exchange measurements two to three months after starting weight reduction
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program with VLCD. In atopic patients measurements were done out of pollen
season.
In Study IV patients measured their daily morning and evening peak flows for
two weeks and recorded the use of rescue medication and symptoms on VAS
scale. Diurnal and day-to-day pulmonary peak flow variability was calculated.
In Study V respiratory gas exchange was measured in supine and standing
positions during orthostatic tolerance test.
4. Statistical methods
In Study I paired t-test was used in comparisons of test results before and after
weight loss and between body positions. For correlation analysis the Pearson
correlation coefficient was calculated.  Wilcoxon signed rank test was used for
comparisons of repeated measurements of lung function and gas exchange data
in Study II and Study III. Spearman’s correlation coefficient was calculated to
determine relationships between variables. In Studies IV-V Wilcoxon signed
rank test was used in paired comparisons of test results between body position
and before and after weight reduction. The Mann-Whitney U-test was used to
compare the active group to controls in Study V. Linear regression analysis
was used for correlation analysis. A p-value of less than 0.05 was considered
to indicate statistical significance.
The data are expressed as mean (SD), mean (range) or median (range). Mean
or median difference with 95 % confidence limits are shown in Study V.
5. Ethical considerations
Studies I-V were approved by the Ethics Committee of the Department of
Pulmonary Medicine at Helsinki University Hospital. Before entering the study
protocol, all patients and control subjects gave their informed consent.
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RESULTS
1. Body fat distribution and pulmonary function in patients with morbid
obesity (I)
The baseline results of waist circumference and waist to hip ratio (W/H) of  15
morbidly obese patients, who started the weight reduction program in Study I,
are shown in Table 4. The patients who later dropped out of the weight loss
trial (n = 4) are included here.
Table 4.  Waist hip ratio (WHR) and waist circumference (WC) in patients
with morbid obesity in Study I.
Patients                  WHR             Weight               BMI              WC
                                         (kg)                (kg/m2)           (cm)
Female (n = 10)           0.94 (0.05)         118.8 (21.9)         45.9 (6.6)       128.7 (17.5
Male  (n = 5)               1.05 (0.04)         148.6 (11.3)         44.1 (4.1)       133.2 (5.4)
All (n = 15)                  0.97 (0.07)        128.7 (23.6)         45.3 (5.8)       130.2 (14.5)
Based on BMI and waist circumference patients were divided into two groups,
as shown in Figure 6. Group II consisted of  8 patients, who had higher BMI or
waist circumference than in group I. Four male patients were included in group
II, whereas in group I there was only one male patient. Waist to hip ratio was
significantly higher in Group II (1.01 (0.05)) than in Group I (0.97(0.07))(p <
0.05) referring to more central distribution of fat in these patients. Pulmonary
function test results between these two groups were compared (Figure 7).
Forced expiratory flows (FEV1 and FVC) and lung volumes measured, using
helium dilution method (VCHe and TLCHe), were significantly lower (Figure 7)
in patients with higher waist circumference or BMI (Group II), whereas FRC
and TLC measured by bodyplethysmograph (FRCB and TLCB) were not
different in these groups.
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Figure 6. Patients with morbid obesity (n = 15) were divided into two groups
based on body mass index (BMI) and waist circumference (WC), o = Group I;
• = Group II; F = female, M = male
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Figure 7. Spirometry and lung volumes in patients with less central obesity
(Group I, n = 7) compared to patients with more central obesity (Group II,
 n = 8). Mann- Whitney U test was used for comparisons between groups.
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2. The effect of weight reduction on pulmonary function (I, III, IV)
The mean weight loss in Study I (morbid obesity) was - 12.8% (range from
- 0,7 to - 32.5%),  -10.8% (range from -5,1 to 17.5%) in OSAS patients, and   -
13.7% (range from -7.6 to -18.4%) among obese asthmatics, Figure 8.
Figure 8.  Weight change (%) from baseline at the time of repeating pulmonary
function tests. Study I: Patients with morbid obesity, n = 11; Study III: Obese patients
with OSAS, n = 13; Study IV: Obese asthmatics, n = 14.
The results of the pulmonary function tests before and after weight loss are
summarized in Table 5. Forced expiratory flow rates (FEV1, FVC, MMEF and
MEF25) were within the 95% confidence limits for the predicted values in
patients with morbid obesity and in OSAS patients. Still, a significant increase
in the flow rates was observed with weight reduction. Initially the mean FEV1
as well as MMEF and MEF25 were low in asthma patients, but normalized
after weight loss. FRC and ERV were markedly reduced in patients with
morbid obesity. With weight reduction the mean FRC and ERV increased
significantly
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Table 5. Pulmonary function data before and after weight reduction. Data are expressed as mean (SD).
 Study I: Morbid obesity       Study III: OSAS        Study IV: Asthmatics
                              Before       After                                    Before      After                                  Before      After    
  weight  loss           p-value                  weight  loss            p-value                 weight loss           p-value
FEV1 (% pred) 95 (10) 101 (15) <0.05 101 (7) 105 (6) <0.05 77 (14) 83 (13) <0.05
FVC (% pred) 91 (10)  97 (13) <0.01  96 (7) 100 (9) <0.05 88 (13) 93 (13) <0.01
FEV1/FVC (%) 86 (4)  85 (4) ns  85 (6)  85 (5) ns 71 (9) 73 (8) ns
MMEF (% pred) 91 (20)  97 (20) ns  98 (27) 105 (26) <0.05 45 (18) 54 (22)  <0.01
FIV1 (L) 4.2 (1.2) 4.4 (1.4) ns 4.9 (0.4) 5.1 (0.4) <0.01
DLco (% pred) 99 (15) 106 (14) <0.05 100 (11) 106 (12) <0.05 103 (11) 103 (13) ns
TLCHe (L) 5.5 (1.4) 5.8 (1.5) ns 6.3 (0.7) 6.8 (0.8) <0.05 4.9 (1.2) 5.0 (1.4) ns
TLCB (L) 5.8 (1.4) 5.9 (1.6) ns 6.5 (0.8) 6.8 (0.8) <0.05 5.3 (1.2) 5.6 (1.4) <0.01
FRCB (% pred) 65 (20) 81 (24) <0.005 71 (7) 85 (12) <0.01 86 (21) 90 (19) ns
ERV (L) 0.4 (0.3) 0.9 (0.7) <0.01 0.8 (0.3) 1.3 (0.4) <0.005 0.4 (0.2) 0.7 (0.5) <0.005
RVB  (% pred) 87 (22) 87 (19) ns 79 (17) 83 (13) ns 116 (26) 113 (25) ns
VCB (% pred) 90 (10) 93 (12) ns 94 (8) 96 (8) <0.05 86 (11) 91 (13) <0.01
Raw (% pred) 201 (88) 154 (50) ns 149 (30) 115 (23) <0.005 329 (166) 252 (112) <0.05
SGaw (% pred) 108 (40) 96 (24) ns 105 (22) 114 (25) ns 52 (31) 61 (40) ns
 p- values refer to the Wilcoxon signed rank test
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in all study groups. Airways resistance (Raw) was within normal range in all
OSAS patients, but was high in patients with asthma. Weight loss induced a
significant decrease in Raw in OSAS group and asthma group but not in
patients with morbid obesity.
The mean value of CV as well as closing capacity (CC = CV + RV) were
within normal range, but because of low FRC closing capacity exceeded FRC
(CC/FRC > 100%) in 10 patients out of 11 with morbid obesity. The mean
CC/FRC was 119 (16)%. After weight reduction CC was higher than FRC
only in three patients, Figure 9. The mean CC/FRC decreased to 92 (17)%
after weight reduction.  In OSAS patients with less severe obesity (III), initial
CC/ FRC was 104 (18)% and after weight reduction 85 (13)%.
Figure 9.  Closing volume (CC) compared to FRC in patients with morbid obesity (I)
and in obese patients with OSAS (III). 1 = before weight reduction; 2 = after weight
reduction. The p-values refer to Wilcoxon signed rank test.
In obese patients with OSAS (III), closing volume was measured also in supine
position both before and after weight loss. A slight decrease in closing volume
was demonstrated in sitting position compared to supine values (p = 0.06
before weight loss; p= 0.01 after weight loss). In response to weight loss, a
significant decrease in closing volume was found in OSAS group (p< 0.05)(III)
but not in patients with morbid obesity (I).
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3. Postural and weight loss induced changes in arterial oxygenation (I-IV)
Results of arterial blood gas analysis are shown in Table 6. In Studies I-III
arterial blood samples were first taken at rest in supine position and after that
in standing position. In Study IV blood samples were taken only in supine
position. In patients with morbid obesity and in OSAS patients the mean
arterial oxygen tension (PaO2) was slightly reduced in supine position.
Standing up induced a significant increase in PaO2. PaCO2 and pH were within
normal range in all patients in both body positions.
Table 6. Results of arterial blood gas analyses in different patient groups. Data
are mean (SD).
    Morbid obesity; OSAS;                            Asthma;
                               Study I        Study III                         Study IV
Before          After             Before         After            Before           After
      weight loss                       weight loss               weight loss
PaO2 (kPa)
   Supine 10.6 (1.4) 10.4 (1.0) 10.3 (0.8) 10.9 (1.1) 11.4 (0.9) 11.9 (1.4)
   Standing       11.6 (1.3) 11.6 (1.3) 11.4 (1.4) 12.1 (1.0)
** * *** ***
PaCO2 (kPa)
   Supine 5.0 (0.4) 5.0 (0.3) 5.4 (0.4) 5.3 (0.3) 5.2 (0.3) 5.2 (0.6)
   Standing 4.7 (0.4) 4.7 (0.5)    5.2 (0.4) 5.1 (0.5)
* **
pH
   Supine 7.42 (0.02) 7.41 (0.01) 7.40 (0.02) 7.41 (0.03) 7.42 (0.01)  7.42 (0.03)
   Standing 7.43 (0.02) 7.42 (0.02) 7.41 (0.02) 7.43 (0.05)
   
P(A-a)O2
  Supine 3.5 (1.3) 3.1 (1.1) 3.2 (0.9) 2.6 (0.9) 2.6 (0.7) 2.5 (1.2)
  Standing 2.9 (1.0) 2.2 (1.1) 2.3 (1.4) 1.6 (0.7)
    * **
* p<0.05, **<0.01, ***p<0.005. Comparisons were made between standing and supine body positions,
and also values after weight loss were  compared with the values before weight loss. P-values refer to the
paired t-test in Study I and the Wilcoxon signed rank test in Study III and IV.
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The effects of weight reduction and standing up on PaO2 as a percentage from
baseline values are shown in Figure 10. With weight reduction no change in
the mean PaO2 in patients with morbid obesity was observed. In OSAS group
the change as a percentage from baseline was +5.5% (p = 0.07). In Study I
there were four patients, who had moderate hypoxemia with PaO2 8.7 – 9.5
kPa. In all these patients, PaO2 increased with weight reduction.
Figure 10. Changes in arterial oxygen tension (PaO2) in response to standing up and
with weight reduction, expressed as a percentage from baseline. PaO2  measured in
standing position was compared with PaO2 measured in supine position, and supine
values after weight loss were also compared with supine values before weight loss
*p<0.05,**p<0.01,***p<0.005
In obese OSAS patients the postural changes in PaO2 and P(A-a)O2, together
with simultaneous changes in closing volume are shown in Figure 11. Closing
volume was recorded in supine and sitting positions before and after weight
reduction. CV/VC% showed a tendency to decrease in sitting position. The
mean CV/VC% was significantly lower in sitting position, compared to supine
values when measurements were done after weight loss. Although the mean
PaO2 increased in standing position before and after weight loss, a rise in PaO2
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in all patients was observed only after weight reduction, Figure 10 and 11. The
postural increase in the mean PaO2 was accompanied by the decrease in
P(A-a)O2
In morbidly obese patients arterial blood gas values were analyzed during
exercise testing (II), Figure 12. At peak exercise, PaO2 was significantly higher
than at rest in supine position. The improvement in PaO2 was observed in
response to standing up. During exercise testing this higher level was
maintained but no further change was demonstrated, Figure 12. Standing up
and light exercise resulted in a significant decrease in P(A-a)O2 (p < 0.05)
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when compared to supine values. With weight reduction blood gases during
exercise did not change. In response to weight loss a significant decrease in
P(A-a)O2 was observed at peak exercise.
Figure 12. Arterial oxygen tension (PaO2) in response to standing up from supine
position and during exercise testing in morbidly obese patients. N = 7.  P-values refer
to the Wilcoxon signed rank test.
4. The effect of weight loss on PEF variability in obese asthmatics (IV)
A significant improvement in the mean morning and evening PEF values with
weight loss was demonstrated. The difference between the daily highest and
lowest PEF did not change. Diurnal PEF variation decreased from 5.5% (2.4)
to 4.5%(1.5) (p = 0.01). PEF indexes over a follow-up period of 14 days before
and after weight loss are shown in Table 7. Calculated from the morning PEF
values over two weeks, the mean difference between the highest and lowest
morning PEF values fell by 38% with weight reduction. Day-to-day PEF
variation decreased from 5.3% (2.6) to 3.1 % (1.1) (p < 0.005).
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Table 7.  PEF indexes before and after VLCD period of eight weeks  in obese
patients with asthma. Values are means (SD).
Before After  p - value
 weight loss weight loss
Morning PEF (l/min) 399 (80) 418 (85) p < 0.001
Evening PEF (l/min) 406 (86) 426 (88) p < 0.005
Lowest morning PEF (l/min) 368 (66) 404 (84) p < 0.001
Highest morning PEF (l/min) 437 (92) 452 (93) ns
Highest - lowest morning PEF (l/min)  63 (35)  39 (10) p < 0.005
p- values refer to the Wilcoxon signed rank test
5. Respiratory gas exchange in obese patients with OSAS and obese
asthmatics (III, IV, V)
The results of pulmonary gas exchange at rest in supine position and during
orthostatic test in standing position in obese OSAS patients, obese asthmatics,
and in healthy subjects are shown in Table 8. Tidal volume was expressed as a
percentage from actual FVC. Minute ventilation (VE) was related to predicted
values of maximal voluntary ventilation (MVV) and oxygen uptake to
predicted values of maximal VO2. Comparisons between patient groups and
control subjects were based on percentage of predicted values in order to
control the differences in gender, age, and height distribution between groups.
VT/FVC% and VE/MVV% at rest as well as VO2/VO2max% were higher in
obese asthmatics than in healthy controls. In obese OSAS patients these values
were not different from the control group. In obese asthma patients minute
ventilation (p< 0.01) and tidal volume decreased after weight reduction (IV,V).
When standardized to body weight, oxygen uptake (VO2/kg) was low in obese
asthmatics and in obese OSAS patients. In asthma group a significant
correlation (r= 0.76, p< 0.05) between initial weight and oxygen consumption
was observed. However, not a significant change in oxygen uptake after
weight loss was  demonstrated.
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Table 8.  Tidal volume expressed as a percentage from FVC (VT/FVC; %),
minute ventilation as a percentage from predicted MVV (VE/MVV; %) and
VO2/kg in OSAS patients (III), in obese asthmatics (V), and in healthy controls
(V).
OSAS; Asthma; Controls;
Study I Study V Study V
Before After Before After
         weight  loss        weight loss
BF (1/min)
Supine 16.2 (3.3) 16.8 (3.4) 16.0 (2.3) 15.0 (3.3) 13.9 (3.1)
Standing 14.5 (3.2) 14.1 (3.9) 15.0 (3.1) 15.0 (3.3) 14.2 (3.2)
VE/MVV (%)
Supine  6.8 (1.4) 6.6 (1.6) 9.0 (1.6)** 7.5 (1.8) 7.0 (1.2)
Standing 8.7 (5) 8.9 (5.4) 11.6 (3.4)** 9.9 (2.9) 8.1 (1.5)
VT/FVC (%)
Supine 11.4 (2.1) 10.3 (1.8) 16.7 (4.1)** 14.1 (3.8) 12.1 (2.3)
Standing 14.2 (2.3) 15.5 (3.5) 23 (7.4)** 18.7 (5.2) 13.9 (2.4)
VO2/kg (ml/min/kg)
Supine 2.7 (0.5)*** 2.7 (0.6)*** 2.5 (0.6)**** 2.8 (0.6)*** 3.5 (1.0)
Standing 3.2 (0.6)** 3.2 (0.9)** 3.0 (0.6)*** 3.3 (0.7)** 3.9 (0.7)
VO2/VO2max (%)
Supine 11.2 (1.9) 9.9 (2.1) 13.1 (3.2)* 12.3 (2.6) 10.4 (2.5)
Standing 13.2 (2.6) 11.6 (2.6) 15.7 (3.7)** 14.9 (3.1)* 11.5 (2.0)
 p< 0.05, **  p< 0.01, ***  p< 0.005, ****  p< 0.001; P-values refer to the Mann-
 Whitney-U-test, which was used for comparisons between patient group and control subjects.
When ventilatory equivalents for O2 (VE/VO2) and CO2 (VE/VCO2) measured
in supine body position were compared before and after weight loss in OSAS
patients and patients with asthma, a significantly different response to weight
loss was observed. OSAS patients showed tendency to increase ventilatory
equivalents after weight loss, while in some asthma patients ventilatory
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equivalents decreased after weight reduction. The individual changes in
VE/VO2 and VE/VCO2 are shown in Figure 13 (III, V).
Figure 13. The changes in ventilatory equivalents for O2 (VE/VO2) and CO2
(VE/VCO2) at rest  in response to weight reduction.
During orthostatic test, however,  ventilatory  equivalents as well as end tidal
CO2 while standing  and change from supine to standing  were not different
from control patients, so that orthostatic response of respiratory gas exchange
did not show tendency to hyperventilation in asthma group or in OSAS
patients (III,V).
VE and VO2/kg were recorded every 30-second interval during orthostatic test
and the mean values of VE and VO2/kg for the asthma group over every
interval were calculated. A close linear correlation between VE and VO2/kg
was found. The slope of the regression line in obese asthma patients was
different from the control group (p< 0.001, asthmatics versus control group
before weight loss;  p< 0.005 asthmatics versus control group after weight
loss; Mann-Whitney U test was used for comparisons) (V).
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DISCUSSION
1. Study population and methods
In Study I-II, patients with morbid obesity were selected because we expected
that the abnormalities in pulmonary function and gas exchange caused by
obesity would be more clearly seen among patients with morbid obesity than
with milder disease. Especially, we assumed to find hypoxemia in supine
position. Most of the previous studies on weight reduction in morbid obesity
have investigated the effects of surgically induced weight loss on respiratory
function. The amount of weight loss following gastric surgery has been over
20 % from initial weight, whereas the mean weight loss after non-surgical
treatments usually has been less than 20%  (Pekkarinen 1999). One of the aims
of this study was to find out, if treatment of obesity with the diet and
behavioral therapy would induce weight loss enough to improve pulmonary
function and gas exchange in short-term.  In this study we did not follow up
the long-term results. The maintenance of weight loss has been poor in some
studies, but behavioral therapy combined with VLCD seems to improve long-
term results (Pekkarinen et al. 1997).
Traditionally, the goal of the weight reduction has been the normalization of
the weight. In most obese patients this is not realistic. Based on reports of
medical benefits of moderate weight reduction, a weight loss of 5% of initial
weight has been regarded as success in some studies (Pekkarinen 1999). In
Study I, the mean weight loss was 12.8 % from initial, which is comparable
with the average achieved using treatment programs including VLCD and
behavior modification. However, the amount of weight loss achieved varied
with a wide range between patients, Figure 8. The differences in initial weight
and variation in weight loss results made it difficult to correlate changes in
weight with improvement in pulmonary function. The mean values for the
group, however, showed that even modest weight loss had significant effects
on pulmonary function and respiratory gas exchange.
The postural effects on arterial blood gases were studied, because we expected
that ventilation perfusion mismatch, which may mainly account for the
hypoxemia of obesity, would be diminished in upright body position. It was
hypothesized that the mechanisms of improvement in arterial oxygenation in
standing body position would be similar to that expected with weight
reduction.
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Previous studies have suggested that the improvement in arterial oxygenation
after weight loss has been demonstrated only if weight was reduced near to
normal weight (Farebrother et al. 1974). With non-surgical treatment of
obesity it seldom is possible to achieve normal or near normal weight, which
may explain why improvement in arterial oxygenation with weight reduction
was not observed in Studies I-II and IV.
There were four female patients who withdrew from the Study I, because they
were not willing to repeat pulmonary function tests and exercise testing which
they regarded as too demanding or they had dropped out the weight reduction
program. The baseline characteristics of all 15 patients started have been
presented in the results of this thesis.
For the studies III-V patients with less severe obesity were selected in order to
achieve weight normalization at least in some patients. In these studies the
follow up period was shorter than in Studies I-II. Pulmonary function tests and
gas exchange analyses were repeated soon after the VLCD period, which in
Study III was 6 weeks and in Study IV-V 8 weeks. The results of weight
reduction were similar in both patient groups. With respect to the age and sex,
groups were different from each other.  Except for one female patient, OSAS
patients were males, whereas in the asthmatic group there was a female
preponderance. Asthmatic patients were older than OSAS patients, with the
mean age of 51.8 (9.1) years. When comparing gas exchange data between
these two groups these differences in study populations have to be taken into
consideration.
In Study IV and V there were 7 patients who had history of allergy to pollen or
skin prick tests had been positive to pollen. Allergic patients were studied out
of pollen season. Asthmatic patients had been advised not to change their anti-
asthmatic treatment other than short-acting β2 - agonists during the study, if the
stability of asthma was clinically acceptable. When the follow-up period was
only 2 months, no need to change the maintenance therapy  was reported. The
dose and timing of long-acting β2 - agonists and sustained-release theophylline
compounds were identical at study visits before and after weight loss. Patients
were advised not to use short-acting bronchodilators for 4 h before pulmonary
function tests including serial PEF measurements at home.
In Studies IV-V asthmatic patients had been followed carefully for one year
before this study so that their asthma could be classified as stable, although
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their expiratory flow volumes were not normal when starting the weight
reduction program in this study.
All patients and subjects in Studies I-V were non-smokers or ex-smokers. Only
patients who had quit smoking at least two years earlier or more were enrolled.
Diffusing capacity was within normal range in all patients including ex-
smokers.
2. Lung volumes and obesity
Ray et al. (1983) suggested that abnormal lung volumes in obese patients are
usually caused by lung disease, not by obesity, except in patients with extreme
obesity. Changes in lung volumes have been classified into two groups, those
that change in proportion to degree of obesity, i.e. ERV and FRC and those
reduced only in extreme obesity, i.e. VC and TLC. Patients with extreme
obesity were then defined as patients whose weight (kg) exceeded height (cm).
Several other studies have reported that the changes in FRV and ERV as well
as VC, TLC and FEV1 are in proportion to the degree of obesity (Rubinstein et
al. 1990, Zerah et al. 1993).
The results of this study give support to the assumption that lung volumes in
morbid obesity fall within the generally accepted 95% confidence limits for the
predicted values. Also in the subgroup of patients with highest BMI and waist
circumference (Group 2 in Figure 6) the mean values of lung volumes were
within normal range. In spite of the normal initial lung volumes, a statistically
significant increase in FEV1, FVC, TLCHe as well as in maximal voluntary
ventilation (MVV) was demonstrated after weight reduction among patients
with morbid obesity.
Previous studies have shown reduced expiratory flow rates in nonsmoking
patients with obesity, especially obese men may have low MEF50 and MEF25
values  (Rubinstein et al. 1990, Zerah et al. 1993). In our study expiratory
flows were not below normal in morbid obesity group or in OSAS patients.
Still, a significant increase in the mean MEF50 was demonstrated after weight
reduction in OSAS patients.
Decreased FRC and ERV have been regarded as the most characteristic
pulmonary function abnormalities in obesity. In this study the 95% confidence
limits for the predicted values of FRC are from 71% to 142% in men and from
74% to 136% in women. The mean FRC was reduced in morbidly obese
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patients and just below normal range in OSAS patients with moderate to
severe obesity. In asthmatic patients with the same degree of obesity as in
OSAS group, the mean initial FCR was within normal range. Individual FRC
values varied in a wide range in asthma patients. With weight reduction FRC
and ERV increased in all patient groups.
What is then the significance of low FRC in obese patients? The relationship
of closing capacity to FRC is important when we evaluate the tendency to
increased small airway closure in obesity. Closing capacity may approach or
exceed the reduced FRC and further lead to a closure of small airways during
tidal breathing and impairment of gas exchange. In studies I and III the CC /
FRC ratio was high before weight loss and a significant decrease was
demonstrated after weight loss, as shown in Figure 9.
The pharyngeal size, as well as the size of intrapulmonary airways, is
dependent on lung volumes (Series et al. 1990). In OSAS patients pharyngeal
size may decrease with decreasing lung volumes (Hoffstein et al. 1984). By
this mechanism reduced FRC may cause pharyngeal narrowing and increase in
airways resistance. Surprisingly, in Study III airways resistance (Raw) was
within normal range in all OSAS patients. Also peak inspiratory flow (PIF)
and forced inspiratory flow in one second (FIV1), which have been regarded as
acceptable variables for detection of laryngeal obstruction (Hoijer et al. 1991)
were normal. Despite the normal initial values, a significant decrease in
airways resistance and increase in FIV1 was observed with weight reduction.
Only in patients with asthma the mean initial Raw was increased. In all patient
groups Raw showed tendency to decrease, which may reflect the changes in
FRC, because airways conductance did not change with weight reduction.
3. Arterial oxygenation and obesity
The improvement in arterial oxygenation in response to change of posture
from supine to standing was observed in patients with morbid obesity and in
sleep apnea patients. In asthmatics arterial oxygenation was measured only in
supine position. When compared to obese OSAS patients, arterial oxygen
tension (PaO2) was significantly higher in obese asthmatics (Table 6). In
response to weight reduction improvement in PaO2 was not demonstrated.
In OSAS patients the changes in PaO2 in response to standing up before and
after weight loss were compared with simultaneous changes in closing volume
(CV) and alveolar arterial O2 difference P(A-a)O2. The increase in PaO2 when
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standing up coincided with the decrease in P(A-a)O2 and a slight decrease in
CV. These findings give support to the assumption that the decrease in airways
closure will improve ventilation and perfusion relationship and oxygenation in
standing position.
Why then was weight reduction not effective in improving arterial
oxygenation? Several previous studies on surgically induced weight loss have
reported a significant increase in PaO2 with weight reduction, but then the
mean weight loss has been over 30 kg (Vaughan et al. 1981, Thomas et al.
1989, Refsum et al. 1990), Table 2. Vaughan et al. (1981) reported a
significant improvement in PaO2 only if change in BMI was more than 20
kg/m2
. 
 Our results showed that the mean change in BMI was 6.0 kg/m2 in
Study I, 3.8 kg/m 2 in Study III and 5.1 kg/m2 in Study IV. Thus it seems that
with moderate weight loss it is not possible to improve arterial oxygenation in
spite of a significant increase in ERV or FRC. Our results give support to the
conclusion Farebrother et al. (1974) stated:  for severely obese subjects it
seems not to be that ”little is good, but more is better”, but rather ”little is no
good, and much is essential”.
4. Respiratory gas exchange and obesity
In morbidly obese patients respiratory gas exchange analysis showed that
oxygen uptake (VO2) at peak exercise did not change with weight reduction
but a significant increase in VO2/kg was observed. Slight increase in
VE/VCO2 and decrease in FETCO2 in morbid obesity after weight reduction
suggested tendency to hyperventilation. When ventilatory equivalents during
orthostatic test were compared between OSAS patients and asthmatics, a
significant difference in changes after weight reduction was observed. OSAS
patients tended to increase VE/VO2 and VE/VCO2 while patients with asthma
showed decreasing tendency in these variables (Figure 11).
5. Asthma and obesity
There are two previous studies on weight loss in obese asthmatics. Dixon et al.
(1999) have reported a significant decrease in asthma score based on standard
questionnaire one year after gastric banding. Decrease in asthma symptoms
and use of rescue medication as well as improvement in pulmonary function
(PEF, FEV1 and FVC) have been demonstrated after dietary treatment of
obese asthmatics (Stenius-Aarniala et al. 2000). Increasing epidemiological
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evidence suggests that there is an association between asthma and obesity. At
present, it is not possible to say, whether obesity has contributed to the rise in
asthma prevalence or whether asthma patients gain weight as a result of
activity limitations or some other reasons. It could be assumed that impairment
in pulmonary mechanics related to obesity, such as reduction in lung volumes,
increased airways resistance and impairment in small airways function may
contribute to an increase in asthma severity.
The mean FEV1 was low before weight loss while the mean FVC was within
normal range (Study IV). As in the study of Stenius-Aarniala et al. (2000) a
significant increase in FEV1 and FVC was observed in our study. FEV1 / FVC
ratio did not change. Thus the increase in FEV1 may reflect overall
improvement in lung volumes rather than decrease in airways obstruction.
Flow rates at low lung volumes (MMEF = FEF25-75) were slightly reduced and
showed a significant increase after weight loss also when related to forced vital
capacity (MMEF/FVC). This finding suggests decreased peripheral airways
obstruction. Also, an increase in FVC may indicate improvement in small
airways obstruction.
The mean values of FRC, VC and TLC were within normal range before
weight loss, but still a significant increase in lung volumes was demonstrated
after weight reduction in morbid obesity group (Study I) as well as OSAS
group (Study III). The most significant improvement in lung volumes was the
increase in expiratory reserve volume (ERV). In chronic asthma RV and FRC
can be elevated because of hyperinflation. In obese asthmatics weight
reduction and a decrease in asthma severity with less inflation of the lungs may
change FRC to opposite directions. This may explain why in our study
individual changes in FRC varied with a wide range. The increase in ERV was
more constant, so that in obese asthmatics changes in ERV better than FRC
may reflect the effects of obesity or weight loss on lung volumes. Airways
resistance was high in obese asthmatics. A significant decrease was
demonstrated with weight reduction, but the mean Raw still remained above
normal. The change in body mass index correlated with the increase in airways
conductance (1/Raw).
In clinical practice, the changes in function of small airways are difficult to
demonstrate. Expiratory flows measured at low lung volumes (MEF50, MEF25,
and MMEF=FEF25-75) have been regarded as measures of peripheral airways
narrowing. As a measure of airways size related to lung size the ratio
MMEF/FVC has been used. Both obesity and asthma can cause excessive
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small airway closure and increase in gas trapping. Of parameters that reflect
small airway obstruction, MMEF was reduced  and increased after weight loss
as well as MMEF /FVC. Also increase in FVC and VC may reflect decreased
small airways obstruction. On the other hand only slight if any gas trapping
was observed based on our data of non ventilated lung compartment (TLCB -
TLCHe).
Increased spontaneous variation in the airway caliber is considered as a
hallmark of asthma. Diurnal variability of PEF has been used as a marker of
airway responsiveness, particularly in epidemiological studies. Several
alternative equations can be used to express PEF variation. In Study IV PEF
variability was expressed in three ways: as diurnal PEF variation, the
difference between the highest and lowest morning PEF values measured over
a follow-up period of 14 days, and day-to-day variation. In obese asthmatics
(Study IV) PEF variability decreased with weight loss, Table 7. The
mechanism of these changes is not clear, but simply the simultaneous increase
in morning and evening PEF could explain the reduction in diurnal variation.
However, this mechanism will not explain the reduction in day-to-day
variation or the decreased difference between lowest and highest morning PEF
over follow-up period. An interesting finding was that the lowest morning PEF
values increased with weight loss while the highest morning PEF remained
unchanged. The mechanism of how weight loss affects PEF variation still
remains unclear. It could be assumed that the decrease in airways obstruction
and improved ventilatory mechanics after weight loss may contribute to a
better control of airways obstruction.
Tendency to rapid shallow breathing pattern has been observed in morbid
obesity (Kaufman et al. 1959), whereas symptomatic patients with chronic
asthma may display increased minute ventilation with increased tidal volume
while breathing frequency is normal (Tobin et al. 1983). Morbidly obese
patients are known to have increased metabolic demands because extra muscle
work must be performed to move an obese body (Dempsey et al. 1966, Luce
1980). Rates of total oxygen consumption (VO2) and carbon dioxide
production (VCO2) are increased even at rest in obesity (Zavala et al. 1984,
Refsum et al. 1990). To meet these increased requirements, minute ventilation
has to be increased. To maintain augmented ventilation, extra work has to be
done because oxygen cost of breathing is high in obesity (Sharp et al. 1964b).
The main reason might be a decrease in chest wall compliance (Naimark et al.
1960).
  .
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In Study V, minute ventilation (VE), tidal volume (VT) and respiratory gases
were continuously monitored during orthostatic tolerance test as described by
Malmberg et al. (2000). The data from five minutes during stable phase in
supine and standing positions was used for calculations of ventilatory gas
exchange variables. The results of the study V showed that in obese asthmatics
resting minute ventilation and tidal volume as a percentage of FVC were
higher than in healthy controls. Thus the breathing pattern of obese asthmatics
in Study V was similar to that previously described in symptomatic patients
with chronic asthma. In response to standing up the increase in ventilation was
in proportion to the changes in oxygen uptake and CO2 production so that
ventilatory equivalents (VE/VO2 and VE/VCO2) were not elevated in standing
position. When using cut-off levels for these parameters suggested by
Malmberg and co-workers (2000), the mean values of VE/VO2 and VE/VCO2
in standing position or changes in ventilation equivalents from supine to
standing ( ∆VE/VO2 and ∆VE/VCO2) were not suggestive of tendency to
hyperventilation.   Increased oxygen cost of breathing associated with obesity
or asthma or both may account for the high resting VO2. The change in
ventilation related to change in oxygen consumption (∆VE/∆VO2/kg) declined
in obese asthmatics after weight reduction.
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SUMMARY
The effects of obesity on respiratory function have been widely studied since
the early 1960s. The characteristic changes in lung volumes i.e. reduction in
FRC and ERV, as well as hypoxemia in supine position are well established.
Most of the study populations, however, have been morbidly obese patients
with many other complications of obesity. In these patients the rapid treatment
of obesity is of vital importance and surgical procedures have been widely
used. Recently, conservative treatment with very-low-calorie diets (VLCD) has
turned out to be effective also in morbid obesity.
One of the aims of the study was to evaluate whether weight reduction
program including VLCD and behavior therapy (BT) would be effective in
improving respiratory complications of morbid obesity. Simultaneously,
changes in pulmonary gas exchange in response to standing up and during
exercise were studied.  A significant improvement in lung volumes with
weight reduction was observed, although lung volumes except FRC and ERV
were within predicted values also before weight loss. The relationship between
closing capacity (CC) and FRC was calculated. In ten patients out of eleven
studied, CC exceeded FRC. Weight reduction converted this relationship in
eight patients. This may suggest improved ventilation to perfusion relationship
and improved arterial oxygenation. Although the mean PaO2 for the study
group did not increase with weight reduction, PaO2 increased in those patients
who had marked hypoxemia before weight loss (n = 4, PaO2 < 9.5 kPa). In
response to standing up, the mean PaO2 increased both before and after weight
loss. (I)
In morbidly obese patients arterial blood gases and respiratory gases were
analyzed during exercise testing. At peak exercise PaO2 was significantly
higher than at rest in supine position. The improvement in PaO2 was observed
in response to standing up and it was maintained during exercise. The increase
in PaO2 was accompanied by decrease in alveolar arterial O2 difference P(A-
a)O2 referring to improvement in ventilation to perfusion abnormalities. With
weight reduction P(A-a) at peak exercise decreased. Respiratory gas analyses
showed that oxygen consumption (VO2) achieved at peak exercise did not
change with weight reduction but a significant increase in oxygen consumption
when related to body weight (VO2/kg) was observed. (II)
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In order to evaluate the impact of obesity on daytime pulmonary function and
gas exchange, OSAS patients with moderate to severe obesity were studied
before and after dietary induced weight loss. CV was measured in supine and
sitting positions. CV values were significantly lower after weight reduction
and  in sitting position. The changes in PaO2 and P(A-a)O2 in response to
standing up were parallel to those demonstrated in patients with morbid
obesity. When changes in daytime arterial oxygen tension were compared to
changes in nocturnal desaturation index (ODI4), a significant positive
correlation was found. On the whole the abnormalities in daytime lung
function and gas exchange were similar to those in morbid obesity. This
similarity suggests that obesity may be the main factor in the pathogenesis of
daytime gas exchange disturbances in obese OSAS patients. (III)
The relationship between asthma and obesity has been under discussion after
several epidemiological studies reported association between asthma and
obesity. In order to evaluate the relation between these two common diseases,
the effects of weight loss on airways obstruction and PEF variability were
compared to simultaneous changes in lung volumes and breathing pattern. The
mean FEV1 was low before weight loss while the mean FVC was within
normal range. A significant increase in FEV1 and FVC was observed, but
FEV1/FVC ratio did not change. Thus the increase in FEV1 may reflect
improvement in lung volumes rather than decrease in airways obstruction.
However, other findings such as increase in MMEF and MMEF/FVC as well
as increase in FVC may reflect decrease in small airway obstruction. Also
reduction in airways resistance (Raw) after weight loss suggests decrease in
obstruction of larger airways. PEF variability expressed as diurnal PEF
variation, day-to-day variation or difference between the highest and lowest
morning PEF during the follow-up period declined with weight reduction.
Bronchial reactivity measured by histamine challenge test did not change. (IV)
The resting minute ventilation and tidal volume are higher in obese asthmatics
than in healthy controls. With weight reduction a significant decrease in
minute ventilation was observed. As a response to change of posture from
supine to standing the rate of increase in ventilation was greater in obese
asthmatics than in non-obese subjects. The increase in ventilation was in
proportion to the changes in VO2 and VCO2 so that ventilation equivalents
were not elevated in standing position. When the change in VE in response to
standing up was related to simultaneous increase in VO2/kg, a significant
decrease in ∆VE/∆VO2/kg was demonstrated with weight reduction. (V)
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CONCLUSIONS
The effects of obesity on pulmonary mechanics and gas exchange must be
known in order to evaluate whether the abnormalities in lung function are
caused by obesity or an existing lung disease. On the other hand, in different
pulmonary diseases the impact of obesity on the severity of the disease should
be considered.
The results of this study suggest that restrictive pattern in spirometry is seldom
caused by obesity alone, except in patients with extreme obesity.  Low  FRC or
ERV seem to be the most characteristic changes in lung volumes and even
modest weight loss is effective in increasing FRC. The low FRC may be
especially unfavorable in lung diseases with airway narrowing, such as
different obstructive lung diseases and OSAS. In obese patients with low FRC,
the airways obstruction as well as gas exchange abnormalities may be
increased in supine position.
The characteristic features for hypoxemia induced by obesity are the
worsening of hypoxemia in supine position and improvement in standing
position. Hypoxemia that improves during exercise testing is typical for
obesity. The results of this study confirm the previous findings that if the goal
of the weight loss is to improve oxygenation then the criteria of successful
treatment should be normalization of weight or at least near normal weight.
The causal relationship between asthma and obesity still remains unclear. It
seems possible that obesity may trigger latent asthma with different
mechanisms but it is unlikely that obesity could cause asthma. Our results
suggest that obesity may worsen airways obstruction both in larger and small
airways.   Obesity with high ventilatory demands as well as increased work of
breathing may be harmful in asthmatics with tendency to hyperventilation. In
addition to these more or less mechanical effects of obesity on lung function,
some indirect mechanisms or cofactors have been suggested. Further studies
will be needed to explain the connection between obesity and respiratory
complications.
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